Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT04368559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

602

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidemia
Mycoses
Fungal Infection
Fungemia
Invasive Candidiasis
Pneumocystis
Mold Infection
Invasive Fungal Disease
Prophylaxis of Invasive Fungal Infections
Aspergillus

Interventions

DRUG: Rezafungin for Injection
DRUG: Posaconazole
DRUG: Fluconazole
DRUG: Trimethoprim-sulfamethoxazole (TMP/SMX)
DRUG: Intravenous Placebo
DRUG: Oral Placebo

Sponsor

Mundipharma Research Limited